IDEXX Laboratories Competitive Intelligence & Landscape

IDEXX Laboratories (idexx.com) is a global leader in veterinary diagnostics, software, and water microbiology testing, listed on NASDAQ since 1991 and a member of the S&P 500TM [idexx.com]. The company's mission is to help pets lead fuller lives by providing veterinarians with the tools, technology, and insights necessary for clear diagnoses and answers [idexx.com]. Beyond companion animals, IDEXX also contributes to ensuring the safety of milk and water globally, and maintaining the health of livestock, poultry, and horses [idexx.com].

The core products and services offered by IDEXX Laboratories span several key areas. For small animal health, they provide reference laboratories, in-house analyzers like Catalyst One and ProCyte One, veterinary software such as Cornerstone and ezyVet, diagnostic imaging and telemedicine consulting, and a range of SNAP tests including the SNAP 4Dx Plus Test [idexx.com]. In the livestock and poultry diagnostics sector, they offer various tests for ruminants, swine, poultry, and equine, alongside testing solutions like Alertys pregnancy tests and RealPCR testing [idexx.com]. Additionally, IDEXX provides dairy tests to reduce antibiotic risk and water microbiology testing [idexx.com].

IDEXX Laboratories' target market primarily includes veterinary professionals in small animal practice, as well as those involved in livestock and poultry health, dairy production, and water quality management [idexx.com]. The company focuses on innovating to advance veterinary medicine and support veterinary professionals in practicing at their best [idexx.com]. Their comprehensive offerings provide solutions for preventative care, cancer diagnostics, kidney health, and vector-borne diseases [idexx.com].

The company's corporate headquarters is located at One IDEXX Drive, Westbrook, Maine 04092, United States [idexx.com].

IDEXX Laboratories, Inc. was incorporated in Delaware [ir.idexx.com] and has been listed on NASDAQ since 1991 [ir.idexx.com]. While specific founding year and company size (e.g., employee count) were not provided, its status as a global leader in its sectors and inclusion in the S&P 500TM indicate a significant enterprise [ir.idexx.com].

IDEXX Laboratories (idexx.com) offers various software and services with distinct pricing structures, although specific detailed pricing plans are often not publicly disclosed and may involve one-time setup fees or subscription models. For instance, Petly Plans involves a "One-time setup fee that includes s" and aims to provide an "easy and affordable" pricing structure that facilitates automated monthly client payments [https://software.idexx.com/products/petly/getting-started]. The IDEXX 360 New Practice Program is designed to be an "affordable way to launch your new veterinary practice," offering "no upfront costs or lease required" and an "Easy-to-meet step-up commitment" that grows with the client base, with "No commitment in year 1" [https://www.idexx.com/en/veterinary/new-practice-program/]. Access to detailed billing and pricing information for existing customers, including programs like IDEXX 360 and IDEXX Points, is typically restricted to administrators via MyIDEXX [https://www.idexx.com/en/veterinary/support/myidexx/].

IDEXX provides a suite of veterinary software solutions.

Neo Veterinary Software is described as a "cost-effective cloud-based solution" that streamlines workflows with an intuitive interface, offering features like a practice dashboard and business snapshot for daily activity overview [https://software.idexx.com/products/neo/features][https://www.idexx.com/en/about-idexx/news/newsroom-archive/idexx-advances-cloud-technology-applications-veterinary-professionals/]. Other offerings include ezyVet, a cloud-based software aiming to save time and grow businesses, and Cornerstone software, a versatile server-based solution with customizable features and diverse integrations for practices of all sizes [https://software.idexx.com/products].

For diagnostic support, IDEXX Laboratories offers Telemedicine Consultants who provide comprehensive diagnostic insights for radiology, cardiology, and other specialty services, available 24/7 [https://www.idexx.com/files/2025-idexx-telemedicine-consultant-service-guide-email-en-us.pdf]. These services include detailed written interpretations of various imaging modalities in conjunction with patient medical history, with different service levels such as nonurgent, routine, priority, and STAT [https://www.idexx.com/media/filer_public/56/9f/569f7046-352b-4a25-8ea1-14fe3db1685f/telemedicine_dos_2022_us.pdf]. Additionally, IDEXX CardioPet ECG Plans are available, integrating with IDEXX software offerings [http://software.idexx.com/integration/idexx-cardiopet-ecg-plans]. Specific pricing for these telemedicine and ECG plans is not detailed publicly, but the services emphasize actionable advice and accurate reports.

IDEXX Laboratories (idexx.com) actively seeks to expand its global workforce, emphasizing its commitment to enhancing the health and well-being of pets, people, and livestock. While specific recent layoff information is not available, the company's career page highlights a continuous need for talent across various crucial departments, indicating a growth-oriented strategy.

IDEXX consistently recruits for positions that align with its core mission. Notable job openings span across Laboratories, Software & Technology, Support, and Sales. For instance, the company seeks laboratory professionals dedicated to delivering insightful information to veterinary practices [careers.idexx.com/us/en/c/laboratories-jobs]. There is also a strong demand for technologists to develop sophisticated solutions for animal and human health, as exemplified by a past opening for an R&D PCR Assay Development Scientist and current interest in a Senior Product Designer for its Vello product [careers.idexx.com/us/en/c/software-technology-jobs].

The company's hiring patterns signal a strategic focus on innovation and customer support. The emphasis on roles in Software & Technology, including for products like Vello, indicates an investment in advancing digital solutions for veterinary medicine. Similarly, the continuous need for Support professionals underscores IDEXX's commitment to strong customer relationships and service delivery [careers.idexx.com/us/en/c/support-jobs].

Furthermore, IDEXX's recruitment for Sales professionals, noting its status as an S&P 500 company and the fastest-growing animal diagnostic provider with over 10,000 employees worldwide, points to an ongoing drive for market expansion and sustained growth in the animal health sector [careers.idexx.com/us/en/sales]. Although a specific job search on their careers site might yield "no results" for certain keywords or locations, IDEXX encourages interested individuals to join its talent community to stay informed about future opportunities, suggesting a proactive approach to talent acquisition [careers.idexx.com/us/en/search-results].

IDEXX Laboratories (idexx.com) demonstrates robust financial performance in the pet healthcare sector. The company reported revenues of $1,141 million for the first quarter of 2026, marking a 14% increase as reported and an 11% organic growth, primarily driven by its Companion Animal Group segment [idexx.com/news-events/press-releases/detail/408/idexx-laboratories-announces-first-quarter-results]. Looking ahead, IDEXX Laboratories has increased its 2026 revenue guidance to a range of $4,675 million to $4,760 million, an uplift of $42 million or approximately 1% at the midpoint, reflecting strong performance in its CAG Diagnostics recurring revenue [idexx.com/news-events/press-releases/detail/408/idexx-laboratories-announces-first-quarter-results].

The initial outlook for 2025 indicated a revenue guidance range of $4,632 million to $4,720 million, projecting reported growth of 7.6% and organic growth between 7.0% and 9.0% [ir.idexx.com/news-events/press-releases/detail/405/idexx-laboratories-announces-fourth-quarter-and-full-year-2025-results]. The IDEXX Laboratories NASDAQ listing (NASDAQ: IDXX) highlights its public trading status, and as of June 30, 2025, the aggregate market value of its voting stock held by non-affiliates was approximately $42.9 billion [ir.idexx.com/sec-filings/all-sec-filings/content/0000874716-26-000038/idxx-20251231.htm].

The company’s financial health is further evidenced by its consolidated balance sheets, which as of a recent period, show total current assets of $1,362,357 (in thousands) and total long-term assets of $2,068,437 (in thousands) [idexx.com/files/10q20250804.pdf]. These figures underscore IDEXX Laboratories' significant asset base and operational scale, reinforcing its position as a global leader in pet healthcare innovation [idexx.com/news-events/press-releases/detail/408/idexx-laboratories-announces-first-quarter-results]. The company’s financial results and outlook are subject to forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995 [ir.idexx.com/financial-results].

IDEXX Laboratories actively participates in a variety of events, primarily focusing on investor relations and veterinary education. The company regularly hosts earnings conference calls, such as the Second Quarter 2026 and First Quarter 2026 Earnings Conference Calls, to communicate financial performance to investors IR calendar :: IDEXX Laboratories, Inc. (IDXX).

IDEXX Laboratories also engages with the investment community through dedicated investor events. They hosted an IDEXX Investor Day 2026 IDEXX Investor Day 2026 :: IDEXX Laboratories, Inc. (IDXX) and have an IDEXX Investor Day 2025 IDEXX Investor Day 2025 :: IDEXX Laboratories, Inc. (IDXX) scheduled. Additionally, they attend institutional investor conferences, with past appearances including the Stifel 2026 Jaws & Paws Conference where President and CEO Mike Erickson participated in a fireside chat IDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor Day :: IDEXX Laboratories, Inc. (IDXX), the 47th Annual Raymond James Institutional Investors Conference 47th Annual Raymond James Institutional Investors Conference :: IDEXX Laboratories, Inc. (IDXX), and the virtual BofA Securities Animal Health Summit virtual BofA Securities Animal Health Summit :: IDEXX Laboratories, Inc. (IDXX).

Beyond investor engagements, IDEXX Laboratories is committed to veterinary education. The company provides the IDEXX Learning Center, which offers over 1,000 free veterinary continuing education courses, including RACE-approved CE, training, and webinars Access over 1000 free veterinary continuing education courses including RACE approved CE, training, webinars, and more at the IDEXX Learning Center.. They also host their own scheduled events to provide more information about the company Upcoming events at IDEXX. Join us to learn more about scheduled events hosted by IDEXX..